跳至主要内容
临床试验/NCT04460664
NCT04460664已完成不适用

Exploratory Assessment of the Coagulation Changes Associated With Severe Inflammation in COVID-19 Patients

HemoSonics LLC1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2020年8月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Quantra Clot Stiffness results

研究概览

简要总结

This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.

详细描述

The Quantra System is a fully integrated and automated in vitro diagnostic device which uses SEER Sonorheometry, an ultrasound-based technology, to characterize the viscoelastic properties of a whole blood sample during coagulation. The QPlus Cartridge can measure hypocoagulable and hypercoagulable conditions resulting from the functional interaction of the enzymatic and cellular components of coagulation and therefore, can be invaluable for longitudinal monitoring of the coagulopathies reported in COVID-19 patients and the response to anticoagulants.

This single-center, prospective, observational pilot study will characterize changes in the coagulation status of patients with COVID-19 infection during their hospital stay using the Quantra QPlus System.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is ≥ 18 years of age
  • Subject has a diagnosis of COVID-19 and has been admitted to the hospital
  • Subject has one or more risk factors for a poor outcome with COVID-10 disease: advanced age (>=60 years), morbid obesity, diabetes, COPD, CAD
  • Subject, or subject's legally authorized representative is willing and agrees to provide informed consent.

排除标准

  • Subject is younger than 18 years of age
  • Subject is pregnant
  • Subject is incarcerated.
  • Subject, or subject's legally authorized representative is unable or unwilling to provide informed consent.
  • Subject is affected by a condition that, in the opinion of the treatment team, may pose additional risks.

结局指标

主要结局

Quantra Clot Stiffness results

时间窗: 1 to 24 hours prior to discharge from hospital

Coagulation function assessed by the Quantra

Quantra Clot Time results

时间窗: 1 to 24 hours prior to discharge from hospital

Coagulation function assessed by the Quantra

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Coagulation Changes Associated With COVID-19... | 临床试验